FDA Inspection 1262513 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Feb 26, 2025 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 26, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Paramus, NJ (United States)